Sinusitis Treatment Market Size is estimated to grow at a CAGR of 5.2% during the forecast period
The sinusitis treatment market was valued at USD 3.0 billion in 2021 and is anticipated to grow at a CAGR of 5.2% from 2022 to 2030.
According to estimates from the Sinus & Allergy
Wellness Center 2021, sinusitis affects more than 30.0 million Americans
annually. Sinusitis is one of the most prevalent upper respiratory tract
illnesses globally, affecting both children and adults.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/sinusitis-treatment-market
GROWTH DRIVERS
The global prevalence of sinusitis and the common cold, the
rising demand for advanced diagnostic techniques and antibiotic development,
the rise in upper respiratory tract infection cases worldwide, and rising
pollution levels, particularly in developing nations, are the main factors
propelling the growth of the global sinusitis treatment market.
Additionally, expanding activities and educational programs
by businesses and hospitals aimed at raising patient knowledge of the
importance of a strong therapeutic approach for sinusitis management and
treatment have been beneficial in boosting the acceptance rate of therapies
globally. Drug companies are thus compelled to create and market fresh
therapeutic approaches as well as introduce cutting-edge respiratory remedies
and cutting-edge diagnostic techniques into the healthcare system.
Additionally, over the past few years, medication makers
have increased their R&D expenditures significantly in order to obtain
regulatory approval from government agencies. As a result, more applications
are being approved. During the projected period, the market's growth is
anticipated to be further supported by the rising investment and approval rate
of medications and therapies.
SINUSITIS TREATMENT MARKET SEGMENTATION
By Disease
· Acute
Sinusitis
· Sub-acute
Sinusitis
· Chronic
Sinusitis
By Treatment
· Analgesics
· Antibiotics
o Penicillin/
Β-lactamase inhibitor combinations
o Macrolide
o Quinolone
o Cephalosporin
· NSAIDS
· Decongestant
and mucolytic
o Corticosteroids
o Antihistamines
o A1 receptor
agonist
o Imidazoline
derivatives
· Nasal
irrigation
· Surgery
o Endoscopy
o Balloon
Sinusplasty
By Route of Administration
· Topical
· Nasal
· Oral
· Injectable
By Distribution Channel
· Online
Pharmacies
· Retail
Pharmacies
· Hospital
Pharmacies
By Region
· North
America
· Europe
· Asia
Pacific
· Latin
America
· Middle
East and Africa
KEY COMPANIES IN SINUSITIS TREATMENT MARKET
· Novartis
AG
· Teva
Pharmaceutical Industries Ltd.
· Sanofi
S.A.
· Abbott
Laboratories Inc.
· Bayer
AG
· Eli
Lilly and Company
· Sun
Pharmaceutical Industries Inc.
· Pfizer
Inc.
· Janssen
Pharmaceuticals Inc.
· Dr.
Reddy's Laboratories Inc.
· Bristol-Myers
Squibb
· Merck
& Co. Inc.
· AstraZeneca
plc
· GlaxoSmithKline
plc.
· Hikma
Pharmaceuticals plc
· Mylan
N.V.
· Olympus
Corporation
· Medtronic
plc
· Stryker
· Cipla
Ltd
· Other
players
For
More Information about this Report @ https://www.xresearch.biz/shop/sinusitis-treatment-market
About
Us: -
xResearch is a market research and consulting organization
that uses unique data, expert analysis, and new technologies to create trusted
intelligence on industries. Our research is focused on delivering an informed
and impartial view on essential market data of industry, and it is primarily
driven by an in-depth study covering the following parameters: Market Sizing
and Forecasting, Market Segmentation, Competitive Analysis, Strategic
Assessment and Business Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-618-4545
Comments
Post a Comment